← SynDRA
PYROTINIB
SynDRA canonical compound SYN0038363 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EGFR | ERBB2 |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- kinase inhibitor
Cross-references
Synonyms
- SHR-1258
- UNII-CJN36EQM0H
- CJN36EQM0H
- SHR1258
- SCHEMBL9948753
- GTPL9662
- SADXACCFNXBCFY-IYNHSRRRSA-N
- BDBM139991
- AKOS032946680
- CS-7940
- compound 12 [PMID: 28115222]
- 2-Propenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-3-((2R)-1-methyl-2-pyrrolidinyl)-, (2E)-
- HY-104065
- US8901140, 5
- (E)-N-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide
- (E)-N-[4-[3-chloro-4-(pyridin-2-ylmetho
- RefChem:177879
- C32H31ClN6O3
- Airuini
- Pyrotinib(SHR-1258)
- PYROTINIB [WHO-DD]
- SCHEMBL29367749
- SCHEMBL29555302
- GLXC-25468
- MSK176426
- s8852
- NCGC00842082-01
- MS-30445
- G16247
- PYROTINIB MALEATE [WHO-DD]
- MS-31512
- Pyrotinib dimaleate (Standard)
- SHR1258 dimaleate
- HY-104065B
- SCHEMBL30341849
- G16295
- UNII-85KUE857XM
- SCHEMBL19512296
Look up PYROTINIB in the interactive SynDRA portal →